University of North Dakota School of Medicine and Health Sciences

George Washington University Hosting Webinar for Clinicians on Culturally Responsive Communication with Patients

Retrieved on: 
Thursday, January 26, 2023
Language, School, GW, COVID, University of North Dakota School of Medicine and Health Sciences, Health, Knowledge, George Washington University, CME, PCP, Communication, Student, COVID-19, Gilead Sciences, SMHS, Gilead, Assistant, Patient, HIV, Racism, Research, Pharmaceutical industry, Nursing, Medicine

WASHINGTON, Jan. 26, 2023 /PRNewswire/ -- The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is hosting a free webinar discussion next month with GW SMHS Professor of Physician Assistant Studies, Dr. Susan LeLacheur, and Assistant Professor of Medicine, Dr. Lalit Narayan on culturally responsive communication within the primary care setting. It is the second webinar in the training series for the Two in One: HIV + COVID Screening and Testing Model.

Key Points: 
  • WASHINGTON, Jan. 26, 2023 /PRNewswire/ -- The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is hosting a free webinar discussion next month with GW SMHS Professor of Physician Assistant Studies, Dr. Susan LeLacheur, and Assistant Professor of Medicine, Dr. Lalit Narayan on culturally responsive communication within the primary care setting.
  • It is the second webinar in the training series for the Two in One: HIV + COVID Screening and Testing Model .
  • GW University is hosting a webinar next month on culturally responsive communication in the primary setting.
  • The webinar, titled "Culturally Responsive Communication in Clinical Care," is a free, CME-bearing panelist discussion that will define culturally responsive communication; discuss the principles of culturally responsive communication; and explain strategies for integrating culturally responsive communication into patient care.

Lack of sexual orientation and gender identity data and research affecting cancer care of LGBTQ+ community

Retrieved on: 
Thursday, May 26, 2022
People, Consensus, Cancer, Program, Prevent Cancer Foundation, Risk, Education, Gender identity, Health equity, Associate professor, Sex, University of North Dakota School of Medicine and Health Sciences, National LGBT Cancer Network, Community health, National Institute, Milken Institute School of Public Health, Foundation for the National Institutes of Health, School, Learning, Measurement, Executive, Health Brigade, Research, Laika (EHR testing framework), National, Data collection, Awareness, CHES, Public health, Outline of health sciences, Health information management, George Washington University, GLOBE, Birth control, Medicine, Sex industry, Policy, Medicine, Engineering

*Despite this uptick, there is a significant lack of data and research on sexual orientation and gender identity when it comes to health care.

Key Points: 
  • *Despite this uptick, there is a significant lack of data and research on sexual orientation and gender identity when it comes to health care.
  • People who identify as LGBTQ+ may have a higher risk of getting cancer than those who identify as heterosexual and/or cisgender.
  • You dont fix what you dont measure, said Scout, Ph.D., the Executive Director of the National LGBT Cancer Network, in reference to how the lack of sexual orientation and gender identity data and research on LGBTQ+ individuals experience with their health care providers affects their outcome of care.
  • Chris Chamars, Program and Partnership Specialist for GRYT Health, discussed their experiences navigating the health care space as a patient, former health care professional and advocate.

Prevent Cancer Advocacy Workshop explores cancer screening disparities in the LGBTQ+ community

Retrieved on: 
Tuesday, May 10, 2022
Measurement, National Institutes of Health, School, Gender identity, Public health, CHES, Gaps, GLOBE, Workshop, National Institute, American Cancer Society, Patient, Organization, University of North Dakota School of Medicine and Health Sciences, Prevent Cancer Foundation, Outline of health sciences, Associate professor, Milken Institute School of Public Health, Health, Health equity, Education, Research, Community health, Sex, George Washington University, Health insurance, Sex industry, Mobile phone, Pharmaceutical industry, Policy, Medicine

Alexandria, Va., May 10, 2022 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation will host its annual Advocacy Workshop virtually on Thursday, March 19.

Key Points: 
  • Alexandria, Va., May 10, 2022 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation will host its annual Advocacy Workshop virtually on Thursday, March 19.
  • The Workshop will explore cancer screening disparities in the LGBTQ+ community, convening patient advocacy organizations and LGBTQ+ community and health experts to discuss the unique barriers faced by the LGBTQ+ community when accessing the health care system.
  • A recent Prevent Cancer Foundation survey found that 47% of LGBTQ+ individuals say their LGBTQ+ status was not disclosed to their health care professional.
  • The lack of data on the needs and experiences of LGBTQ+ people is a barrier, but the Prevent Cancer Advocacy Workshop will help us better determine what needs to change to lessen disparities in cancer risk, screening and treatment, said Caitlin Kubler, Director of Policy and Advocacy at the Prevent Cancer Foundation.

ImmunoGen Appoints Helen M. Thackray, MD to its Board of Directors

Retrieved on: 
Wednesday, September 22, 2021
Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Science, University of North Dakota School of Medicine and Health Sciences, ImmunoGen, BLA, School, BPDCN, Annual report, Security (finance), Board of directors, Private Securities Litigation Reform Act, Drug, U.S. Securities and Exchange Commission, Cancer, Patient, Outline of health sciences, Development, Glycomimetic, Board, Senior, Bachelor of Science in Human Biology, Compugen (Israeli company), FAAP, American Academy, IMGN, George Washington University School of Medicine & Health Sciences, Pediatrics (journal), Company, Control, Stanford University, COVID-19, Acute myeloid leukemia, View, Research, Lymphatic system, George Washington University, BioCryst Pharmaceuticals, Industry, Director, Vaccine, Pharmaceutical industry

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Helen M. Thackray, MD, FAAP to its Board of Directors.

Key Points: 
  • ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the appointment of Helen M. Thackray, MD, FAAP to its Board of Directors.
  • "Helen joins ImmunoGen's Board of Directors at an exciting time, as we advance multiple programs in the clinic and transform ImmunoGen into a fully integrated oncology company with the potential to launch two innovative ADCs next year," said Stephen McCluski, ImmunoGen's Chairman of the Board of Directors.
  • Dr. Thackray has over 25 years of biopharmaceutical, clinical research, and bench research experience.
  • Dr. Thackray stated, "ImmunoGen has established a leadership position in ADCs and built a strong pipeline targeting solid tumors and hematologic malignancies.

CCRM Fertility Announces New Satellite Office in Fargo

Retrieved on: 
Thursday, August 5, 2021
Essentia, National Committee, Chief executive officer, Research, Industry, American Association of Clinical Endocrinologists, Reproductive medicine, Science, University of North Dakota School of Medicine and Health Sciences, Genetic testing, University, Quality assurance, Obstetrics, Fertility, Partnership, Fertility clinic, Gynaecology, Patient, Essentia Health, Infertility, Essence, Western Colorado Center for the Arts, Reproduction, Department, Fertility preservation, Multimedia, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Knowledge, In vitro fertilisation, Hospital, National Committee for Quality Assurance, Accountable care organization, Physician, Medical device

FARGO, N.D., Aug. 5, 2021 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility treatment, research and science, today announced the expansion of its Minneapolis treatment network with the opening of a new satellite office within Essentia Health-Fargo, 3000 32nd Avenue South in Fargo, North Dakota.

Key Points: 
  • FARGO, N.D., Aug. 5, 2021 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility treatment, research and science, today announced the expansion of its Minneapolis treatment network with the opening of a new satellite office within Essentia Health-Fargo, 3000 32nd Avenue South in Fargo, North Dakota.
  • Beginning August 30, reproductive endocrinologist Dr. Stephanie Dahl will see patients out of the CCRM Minneapolis Fargo office, located at Essentia Health.
  • The new Fargo satellite office will offer individuals and couples a convenient location to experience a range offertility services, includingnew patient consultations, treatment planning, regroups, and monitoring (blood work and ultrasounds).
  • Founded by Dr. William Schoolcraft in 1987, CCRM (Colorado Center for Reproductive Medicine)Fertilityis the nation's leader in fertility care and research.